Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Johnson & Johnson

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.

Johnson & Johnson

New leader at Medivir after setbacks

New leader at Medivir after setbacks

Meanwhile, last year Johnson &Johnson ducked out of a partnership on a hepatitis C virus programme after deciding the market opportunity wasn’t sufficiently attractive.

The case for a second Brexit referendum: “We need the informed consent of the people”

The case for a second Brexit referendum: “We need the informed consent of the people” Meanwhile, a very vocal group of around 21 Conservative MPs, including the likes of Boris Johnson and Jacob Rees-Mogg, is agitating for a hard Brexit – embodied by the ‘Canada ... However this ‘cherry-picking’approach has been repeatedly rebuffed

Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit

Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit High Throughput Centres just make sense for the international clinical research industry as well as for the UK specifically, ”said Jacqueline Johnson North, CEO and co-founder of IAOCR.

Geron poleaxed as partner J&J abandons only pipeline drug

Geron poleaxed as partner J&J abandons only pipeline drug Johnson &Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat, wiping two-thirds off the biotech’s share price at a stroke.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics